Actively personalized vaccination trial for newly diagnosed glioblastoma
2018 · Nature · 897 citations
https://doi.org/10.1038/s41586-018-0810-y
M
Martin Löwer
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
96
Papers
9.8K
Citations
30
h-index
40
i10-index
Martin Löwer is an academic researcher from Johannes Gutenberg University Mainz. The author has contributed to research in topics: Immunotherapy and Immune Responses & vaccines and immunoinformatics approaches & Cancer Immunotherapy and Biomarkers. The author has an h-index of 30, co-authored 82 publications.
Papers by this author
worksTargeting immune checkpoints potentiates immunoediting and changes the dynamics of tumor evolution
2017 · Nature Communications · 308 citations
https://doi.org/10.1038/s41467-017-02424-0
HLA typing from RNA-Seq sequence reads
2012 · Genome Medicine · 300 citations
https://doi.org/10.1186/gm403
HLA and proteasome expression body map
2018 · BMC Medical Genomics · 112 citations
https://doi.org/10.1186/s12920-018-0354-x
Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial
2025 · Nature Medicine · 76 citations
https://doi.org/10.1038/s41591-024-03334-7
Instruction of haematopoietic lineage choices, evolution of transcriptional landscapes and cancer stem cell hierarchies derived from an <scp>AML</scp> 1‐ <scp>ETO</scp> mouse model
2013 · EMBO Molecular Medicine · 39 citations
https://doi.org/10.1002/emmm.201302661
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat